ATE426817T1 - Verfahren zur identifizierung von proteinfaltungsinhibitoren - Google Patents
Verfahren zur identifizierung von proteinfaltungsinhibitorenInfo
- Publication number
- ATE426817T1 ATE426817T1 AT06762655T AT06762655T ATE426817T1 AT E426817 T1 ATE426817 T1 AT E426817T1 AT 06762655 T AT06762655 T AT 06762655T AT 06762655 T AT06762655 T AT 06762655T AT E426817 T1 ATE426817 T1 AT E426817T1
- Authority
- AT
- Austria
- Prior art keywords
- protein folding
- identifying protein
- inhibitors
- folding inhibitors
- relates
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 230000012846 protein folding Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000008827 biological function Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20050015597 EP1746422A1 (de) | 2005-07-19 | 2005-07-19 | Verfahren zur Identifizierung von Inhibitoren der Faltung der Proteine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE426817T1 true ATE426817T1 (de) | 2009-04-15 |
Family
ID=34937871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06762655T ATE426817T1 (de) | 2005-07-19 | 2006-07-17 | Verfahren zur identifizierung von proteinfaltungsinhibitoren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080199965A1 (de) |
| EP (2) | EP1746422A1 (de) |
| JP (1) | JP5280202B2 (de) |
| CN (1) | CN101228443B (de) |
| AT (1) | ATE426817T1 (de) |
| BR (1) | BRPI0613417A2 (de) |
| CA (1) | CA2614236A1 (de) |
| DE (1) | DE602006005932D1 (de) |
| ES (1) | ES2323654T3 (de) |
| PT (1) | PT1904854E (de) |
| WO (1) | WO2007009727A1 (de) |
| ZA (1) | ZA200800267B (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999040435A1 (en) * | 1998-02-09 | 1999-08-12 | Netzer William J | Protein folding inhibitors |
| WO2001034631A2 (en) * | 1999-11-05 | 2001-05-17 | Axonyx, Inc. | PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| US6689753B1 (en) * | 1999-11-05 | 2004-02-10 | Axonyx, Inc. | β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide |
-
2005
- 2005-07-19 EP EP20050015597 patent/EP1746422A1/de not_active Withdrawn
-
2006
- 2006-07-17 ES ES06762655T patent/ES2323654T3/es active Active
- 2006-07-17 CA CA 2614236 patent/CA2614236A1/en not_active Abandoned
- 2006-07-17 CN CN2006800265608A patent/CN101228443B/zh not_active Expired - Fee Related
- 2006-07-17 DE DE200660005932 patent/DE602006005932D1/de active Active
- 2006-07-17 PT PT06762655T patent/PT1904854E/pt unknown
- 2006-07-17 EP EP20060762655 patent/EP1904854B9/de not_active Not-in-force
- 2006-07-17 BR BRPI0613417-3A patent/BRPI0613417A2/pt not_active IP Right Cessation
- 2006-07-17 ZA ZA200800267A patent/ZA200800267B/xx unknown
- 2006-07-17 AT AT06762655T patent/ATE426817T1/de not_active IP Right Cessation
- 2006-07-17 JP JP2008521864A patent/JP5280202B2/ja not_active Expired - Fee Related
- 2006-07-17 WO PCT/EP2006/007018 patent/WO2007009727A1/en not_active Ceased
- 2006-07-17 US US11/995,820 patent/US20080199965A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009501535A (ja) | 2009-01-22 |
| EP1904854B1 (de) | 2009-03-25 |
| EP1904854A1 (de) | 2008-04-02 |
| CN101228443B (zh) | 2013-03-27 |
| EP1904854B9 (de) | 2009-12-16 |
| EP1746422A1 (de) | 2007-01-24 |
| US20080199965A1 (en) | 2008-08-21 |
| JP5280202B2 (ja) | 2013-09-04 |
| BRPI0613417A2 (pt) | 2011-01-11 |
| HK1115918A1 (en) | 2008-12-12 |
| ES2323654T3 (es) | 2009-07-22 |
| CN101228443A (zh) | 2008-07-23 |
| CA2614236A1 (en) | 2007-01-25 |
| WO2007009727A1 (en) | 2007-01-25 |
| PT1904854E (pt) | 2009-07-01 |
| ZA200800267B (en) | 2009-04-29 |
| DE602006005932D1 (de) | 2009-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005021336D1 (de) | Verfahren zur identifizierung von proteinen mit stärkephosphorylierender enzymatischer aktivität | |
| ATE540114T1 (de) | Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle | |
| ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
| ATE545712T1 (de) | Verfahren mit verwendung von poren | |
| DE60330842D1 (de) | Für den nachweis von nukleinsäuren kompetente biologische rohderivate | |
| DK1534830T3 (da) | In vito-peptid-ekspressionsbibliotek | |
| ATE348881T1 (de) | Thermostabiles taq polymerase fragment | |
| ATE474847T1 (de) | Verfahren zur herstellung von dipeptiden | |
| ATE393237T1 (de) | Mittel und verfahren zur in-vitro-bestimmung von camp | |
| ATE416619T1 (de) | Verfahren zur dearomatisierung von molkeprotein | |
| DE60323579D1 (de) | Methode zur Separierung von Nukleinsäuren und dafür verwendbare Reagenz | |
| ATE487792T1 (de) | Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen | |
| ATE506370T1 (de) | Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen | |
| DE50207801D1 (de) | Verfahren zum Nachweis prokaryontischer DNA | |
| ATE533837T1 (de) | Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen | |
| ATE383418T1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine | |
| ATE426817T1 (de) | Verfahren zur identifizierung von proteinfaltungsinhibitoren | |
| ATE452984T1 (de) | Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen | |
| WO2006079334A3 (de) | Verfahren zu nachweis und quantifizierung von proteinen unter verwendung von farbstoffen auf der basis von polymethinen | |
| ATE547161T1 (de) | Verfahren zur quantitativen bestimmung von poloxameren | |
| DE60218848D1 (de) | Verfahren zur trennung und/oder zum nachweis und/oder zur identifizierung und/oder zur quantifizierung von prionproteinen | |
| ATE421733T1 (de) | Methode zur identifizierung von unbekannten proteinen mittels zwei-dimensionaler auftrennung und verwendung von markern | |
| WO2006094185A3 (en) | Quantification of proteins | |
| WO2004094989A3 (en) | Methods of host cell protein analysis | |
| ATE421698T1 (de) | Intrinsic-faktor vom schwein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |